Clinical trial reportJAMA network openPublished
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial
Regional connection
Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source
- Institution
- Thomas Jefferson University
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- JAMA network open
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Adenocarcinoma; Carcinoma, Pancreatic Ductal; Pancreatic Neoplasms; Paclitaxel; Albumins; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal; Adult; Aged; Middle Aged; Female
- PubMed ID
- 36602796
- PubMed Central ID
- PMC9856813
- Open access
- Yes, open
- Added to directory
- Source checked